Provides Update on Transformation Plan and Full Year 2020 Guidance
ELYRIA, Ohio–(BUSINESS WIRE)–Invacare Corporation (NYSE: IVC) (“Invacare” or the “company”) announces that it will release its financial results for the fourth quarter and year ended December 31, 2019, on Monday, February 10, 2020 at 6:00 a.m. ET, followed by a live conference call and webcast to discuss these financial results at 8:30 AM ET.
In addition, the company will be providing an update on its transformation plan and full year guidance for 2020.
Investors and other interested parties may access the conference call and webcast in the following ways:
- Those wishing to participate in the live call should dial 888-204-4368, or for international callers 786-789-4797, and enter Conference ID Code 7513108.
- Those wishing to participate via webcast can register and access the call at https://ctevents.webex.com/ctevents/onstage/g.php?MTID=e0ab99d7d29ab7ed012908b3341034cea
- A copy of the webcast slide deck will be posted to www.invacare.com/investorrelations prior to the webcast.
- A recording of the conference call can be accessed by dialing 888-203-1112 (U.S. and Canada) or 719-457-0820 (international callers) and entering the Conference ID Code 7513108, through February 17, 2020.
- An archive of the webcast presentation will be posted at www.invacare.com/investorrelations 24 hours after the call.
About Invacare Corporation
Invacare Corporation is a leading manufacturer and distributor in its markets for medical equipment used in non-acute care settings. At its core, the company designs, manufactures and distributes medical devices that help people to move, breathe, rest and perform essential hygiene. The company provides clinically complex medical device solutions for congenital (e.g., cerebral palsy, muscular dystrophy, spina bifida), acquired (e.g., stroke, spinal cord injury, traumatic brain injury, post-acute recovery, pressure ulcers) and degenerative (e.g., ALS, multiple sclerosis, chronic obstructive pulmonary disease (COPD), elderly, bariatric) ailments. The company’s products are important parts of care for people with a wide range of challenges, from those who are active and involved in work or school each day and may need additional mobility or respiratory support, to those who are cared for in residential care settings, at home and in rehabilitation centers. The company sells its products principally to home medical equipment providers with retail and e-commerce channels, residential care operators, distributors and government health services in North America, Europe and Asia/Pacific. For more information about the company and its products, visit Invacare’s website at www.invacare.com.